 Analgesics
|
Anesthetics
|
Anti-Addiction/Substance Abuse Treatment Agents
|
Antibacterials
|
Anticonvulsants
|
Antidementia Agents
|
Antidepressants
|
Antiemetics
|
Antifungals
|
Antigout Agents
|
Antimigraine Agents
|
Antimyasthenic Agents
|
Antimycobacterials
|
Antineoplastics
|
Anti-Obesity Agents
|
Antiparasitics
|
Antiparkinson Agents
|
Antipsychotics
|
Antispasticity Agents
|
Antivirals
|
Anxiolytics
|
Bipolar Agents
|
Blood Glucose Regulators
|
Blood Products and Modifiers
|
Cardiovascular Agents
|
Central Nervous System Agents
|
Contraceptives
|
Dental and Oral Agents
|
Dermatological Agents
|
Electrolytes/Minerals/Metals/Vitamins
|
Gastrointestinal Agents
|
Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
|
Genitourinary Agents
|
Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
|
Hormonal Agents, Stimulant/Replacement/Modifying (Pituitary)
|
Hormonal Agents, Stimulant/Replacement/Modifying (Prostaglandins)
|
Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
|
Hormonal Agents, Stimulant/Replacement/Modifying (Thyroid)
|
Hormonal Agents, Suppressant (Pituitary)
|
Hormonal Agents, Suppressant (Thyroid)
|
 Immunological Agents
|
Angioedema Agents
|
Immunoglobulins
|
Immunostimulants
|
Immunosuppressants
|
Antimetabolites, Antiproliferative
|
Antimetabolites, Purine
|
Calcineurin Inhibitors
|
Cyclosporine
|
 D00184 Cyclosporine (USP)
|
Tacrolimus [DG:DG00439]
|
Voclosporin
|
mTOR Inhibitors
|
Tumor Necrosis Factor (TNF) Blockers
|
Immunosupressants, Other
|
Vaccines
|
Immunological Agents, Other
|
Infertility Agents
|
Inflammatory Bowel Disease Agents
|
Metabolic Bone Disease Agents
|
Ophthalmic Agents
|
Intraocular Pressure Lowering Agents
|
Ophthalmic Anti-allergy Agents
|
Ophthalmic Anti-Infectives
|
Ophthalmic Anti-inflammatories
|
Ophthalmic Agents, Combinations
|
Ophthalmic Agents, Other
|
Cyclopentolate [DG:DG01141]
|
Oxymetazoline [DG:DG01029]
|
Inebilizumab
|
Satralizumab
|
Teprotumumab
|
Cenegermin
|
Aflibercept
|
Brolucizumab
|
Faricimab
|
Ranibizumab
|
Avacincaptad Pegol
|
Cyclosporine
|
D00184 Cyclosporine (USP)
|
Hydroxypropyl Cellulose
|
Lifitegrast [DG:DG01389]
|
Perfluorohexyloctane
|
Phenylephrine
|
Varenicline [DG:DG00995]
|
Tropicamide
|
Otic Agents
|
Respiratory Tract/Pulmonary Agents
|
Sexual Disorder Agents
|
Skeletal Muscle Relaxants
|
Sleep Disorder Agents
|
USP Drug Classification